Medicenna Therapeutics (MDNA) Competitors C$1.50 0.00 (0.00%) (As of 12:00 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades MDNA vs. VBV, CUS, AIM, FRX, APM, IPA, CRDL, GXE, ITH, and GPHShould you be buying Medicenna Therapeutics stock or one of its competitors? The main competitors of Medicenna Therapeutics include VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), Fennec Pharmaceuticals (FRX), Andean Precious Metals (APM), ImmunoPrecise Antibodies (IPA), Cardiol Therapeutics (CRDL), Gear Energy (GXE), International Tower Hill Mines (ITH), and Graphite One (GPH). These companies are all part of the "pharmaceutical products" industry. Medicenna Therapeutics vs. VBI Vaccines Chemtrade Electrochem Inc, Aimia Fennec Pharmaceuticals Andean Precious Metals ImmunoPrecise Antibodies Cardiol Therapeutics Gear Energy International Tower Hill Mines Graphite One Medicenna Therapeutics (TSE:MDNA) and VBI Vaccines (TSE:VBV) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, community ranking, valuation and profitability. Does the MarketBeat Community prefer MDNA or VBV? Medicenna Therapeutics received 37 more outperform votes than VBI Vaccines when rated by MarketBeat users. However, 70.83% of users gave VBI Vaccines an outperform vote while only 68.22% of users gave Medicenna Therapeutics an outperform vote. CompanyUnderperformOutperformMedicenna TherapeuticsOutperform Votes8868.22% Underperform Votes4131.78% VBI VaccinesOutperform Votes5170.83% Underperform Votes2129.17% Is MDNA or VBV more profitable? VBI Vaccines' return on equity of 0.00% beat Medicenna Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Medicenna TherapeuticsN/A -105.43% -32.80% VBI Vaccines N/A N/A N/A Does the media refer more to MDNA or VBV? In the previous week, Medicenna Therapeutics had 2 more articles in the media than VBI Vaccines. MarketBeat recorded 2 mentions for Medicenna Therapeutics and 0 mentions for VBI Vaccines. Medicenna Therapeutics' average media sentiment score of 0.00 equaled VBI Vaccines'average media sentiment score. Company Overall Sentiment Medicenna Therapeutics Neutral VBI Vaccines Neutral Do insiders and institutionals believe in MDNA or VBV? 13.0% of Medicenna Therapeutics shares are held by institutional investors. 22.6% of Medicenna Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has stronger valuation and earnings, MDNA or VBV? Medicenna Therapeutics has higher earnings, but lower revenue than VBI Vaccines. Medicenna Therapeutics is trading at a lower price-to-earnings ratio than VBI Vaccines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedicenna TherapeuticsN/AN/A-C$26.24M-C$0.38-3.95VBI VaccinesC$3.36M0.00-C$62.16M-C$0.97N/A SummaryMedicenna Therapeutics beats VBI Vaccines on 7 of the 11 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Medicenna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDNA vs. The Competition Export to ExcelMetricMedicenna TherapeuticsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$114.65MC$163.76MC$5.09BC$6.18BDividend YieldN/A3.50%5.04%5.31%P/E Ratio-3.95329.4793.0926.62Price / SalesN/A14,840.741,220.671,497.24Price / Cash1.1511.6739.4982.35Price / Book5.007.056.933.13Net Income-C$26.24M-C$18.37MC$118.83MC$292.70M7 Day Performance-11.76%0.16%-1.74%1.27%1 Month Performance-32.43%8.26%-3.60%13.11%1 Year Performance226.09%25.75%31.91%44.20% Medicenna Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDNAMedicenna TherapeuticsN/AC$1.50flatN/A+252.9%C$114.65MN/A-3.9520Gap UpVBVVBI VaccinesN/AN/AN/AN/AC$308.86MC$3.36M-4.9722CUSChemtrade Electrochem Inc,N/AN/AN/AN/AC$306.50MN/A0.0060AIMAimia2.1932 of 5 starsC$2.47-0.4%C$4.00+61.9%-16.8%C$243.00MC$396.20M-1.8620FRXFennec PharmaceuticalsN/AC$6.82+4.9%N/A-42.5%C$186.60MC$48.89M64.7010Analyst UpgradeNews CoverageGap UpAPMAndean Precious Metals1.2882 of 5 starsC$1.20+1.7%C$1.70+41.7%N/AC$179.23MC$199.84M3.1130Negative NewsGap UpIPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownCRDLCardiol TherapeuticsN/AC$2.09-4.1%N/A+80.2%C$146.05MN/A-4.9520GXEGear Energy2.8936 of 5 starsC$0.53+3.9%C$1.00+88.7%-27.1%C$139.70MC$134.93M10.201,310Dividend AnnouncementNegative NewsITHInternational Tower Hill MinesN/AC$0.61-4.7%N/A+33.3%C$121.81MN/A-21.33220GPHGraphite OneN/AC$0.74-1.3%N/A-27.5%C$102.55MN/A-10.5720 Related Companies and Tools Related Companies VBI Vaccines Alternatives Chemtrade Electrochem Inc, Alternatives Aimia Alternatives Fennec Pharmaceuticals Alternatives Andean Precious Metals Alternatives ImmunoPrecise Antibodies Alternatives Cardiol Therapeutics Alternatives Gear Energy Alternatives International Tower Hill Mines Alternatives Graphite One Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:MDNA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicenna Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicenna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
